BioCentury | Jun 5, 2018
Distillery Techniques

Drug platforms

...TECHNOLOGY: Antibody scaffolds A murine leukemia virus (MLV)-like particle-based immunization method could be used to generate...
...generate immunogenic membrane-enveloped MLV-like particles containing the antigen; immunizing chickens with the particles; screening in MLV-like...
BioCentury | Apr 18, 2016
Financial News

Amyris financial update

...an at-the-market program to sell up to $50 million of its shares. FBR Capital and MLV...
BioCentury | Oct 26, 2015
Financial News

Mapi-Pharma amends IPO

...IPO on NASDAQ and removed the proposed amount to be raised. The company also removed MLV...
BioCentury | Sep 7, 2015
Financial News

Mapi-Pharma amends IPO

...be raised: Up to $57.5 million Shares: TBD Price: TBD Underwriters: JMP Securities; Maxim Group; MLV...
...The company also removed Aegis and Chardan as underwriters and added JMP Securities; Maxim; and MLV...
BioCentury | Aug 4, 2015
Financial News

Financial tracks

...Raghuram Selvaraju as managing director in equity research. Selvaraju was a senior biotechnology analyst at MLV. BC...
BioCentury | Aug 3, 2015
Financial News

NantKwest completes IPO

...Price: $25 Shares after offering: 78.9 million Underwriters: BofA Merrill Lynch; Citigroup; Jefferies; Piper Jaffray; MLV...
BioCentury | Aug 3, 2015
Finance

NK-ocking out cancer

...to sell 7 million shares at $20-$23. BofA Merrill Lynch, Citigroup, Jefferies, Piper Jaffray and MLV...
BioCentury | Jul 29, 2015
Financial News

NantKwest gains in trading debut

...rounds (see BioCentury Extra, June 25) . BofA Merrill Lynch; Citigroup; Jefferies; Piper Jaffray; and MLV...
BioCentury | Jul 20, 2015
Financial News

RedHill completes follow-on

...Shares: 2.5 million Price: $16.25 Shares after offering: 12.4 million Underwriters: Nomura; Roth Capital Partners; MLV...
BioCentury | Jul 20, 2015
Financial News

NantKwest amends IPO

...$161 million Shares: 7 million Price: $20-$23 Underwriters: BofA Merrill Lynch; Citigroup; Jefferies; Piper Jaffray; MLV...
Items per page:
1 - 10 of 148
BioCentury | Jun 5, 2018
Distillery Techniques

Drug platforms

...TECHNOLOGY: Antibody scaffolds A murine leukemia virus (MLV)-like particle-based immunization method could be used to generate...
...generate immunogenic membrane-enveloped MLV-like particles containing the antigen; immunizing chickens with the particles; screening in MLV-like...
BioCentury | Apr 18, 2016
Financial News

Amyris financial update

...an at-the-market program to sell up to $50 million of its shares. FBR Capital and MLV...
BioCentury | Oct 26, 2015
Financial News

Mapi-Pharma amends IPO

...IPO on NASDAQ and removed the proposed amount to be raised. The company also removed MLV...
BioCentury | Sep 7, 2015
Financial News

Mapi-Pharma amends IPO

...be raised: Up to $57.5 million Shares: TBD Price: TBD Underwriters: JMP Securities; Maxim Group; MLV...
...The company also removed Aegis and Chardan as underwriters and added JMP Securities; Maxim; and MLV...
BioCentury | Aug 4, 2015
Financial News

Financial tracks

...Raghuram Selvaraju as managing director in equity research. Selvaraju was a senior biotechnology analyst at MLV. BC...
BioCentury | Aug 3, 2015
Financial News

NantKwest completes IPO

...Price: $25 Shares after offering: 78.9 million Underwriters: BofA Merrill Lynch; Citigroup; Jefferies; Piper Jaffray; MLV...
BioCentury | Aug 3, 2015
Finance

NK-ocking out cancer

...to sell 7 million shares at $20-$23. BofA Merrill Lynch, Citigroup, Jefferies, Piper Jaffray and MLV...
BioCentury | Jul 29, 2015
Financial News

NantKwest gains in trading debut

...rounds (see BioCentury Extra, June 25) . BofA Merrill Lynch; Citigroup; Jefferies; Piper Jaffray; and MLV...
BioCentury | Jul 20, 2015
Financial News

RedHill completes follow-on

...Shares: 2.5 million Price: $16.25 Shares after offering: 12.4 million Underwriters: Nomura; Roth Capital Partners; MLV...
BioCentury | Jul 20, 2015
Financial News

NantKwest amends IPO

...$161 million Shares: 7 million Price: $20-$23 Underwriters: BofA Merrill Lynch; Citigroup; Jefferies; Piper Jaffray; MLV...
Items per page:
1 - 10 of 148